COPD Treatment Landscape
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
January 19, 2024
by David Orchard-Webb
What are the new developments of the CNS drug R&D?
The research and development of Central Nervous System (CNS) drugs have been the focus of ongoing advancements and innovations.
November 8, 2023
by ChatGPT/PharmaSources
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to evaluate the combination of each party's clinical candidate, olinvacimab and C-005, a 3rd generation of EGFR inhibitor with superior b
August 4, 2020
by prnasia
Pharmaceutical News of the Week (July. 6th-July. 10th) PharmaSources.com - Updates on Policies,Transactions and Others
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
July 21, 2020
by PharmaSources/Caicai
FDA launches new programme to speed-up Covid-19 therapies
The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
April 2, 2020
by pharmaceutical-technology
Testosterone Supplements Won't Help Most Men, Doctors' Group Says
Testosterone therapy is no fountain of youth for older men, though it might help some who are impotent.That's according to new guidelines from the American College of Physicians -- the first from the group to address the issue of treating age-related "low
January 7, 2020
by drugs
China's first self-developed carbon-ion therapy system gets market access
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
October 16, 2019
by NMPA
US researchers develop CAR T cell therapy for cancer
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.
September 27, 2019
by pharmaceutical-technology
BioMarin Submits CTA in UK for Investigational Gene Therapy for PKU
BioMarin Pharmaceutical has submitted a Clinical Trial Application (CTA) with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for BMN 307 ...
September 27, 2019
by americanpharmaceuticalreview
Cryoport's New Shipper for Advanced Therapies
Cryoport has launched its Advanced Therapy Shipper product line for the regenerative medicine market. The Advanced Therapy Shipper guarantees each shipper has been used only for human use and ...
September 26, 2019
by contractpharma
Initiating Empirical Tx for Sepsis Reduces Blood Culture Sensitivity
When empirical antimicrobial therapy is initiated in patients with severe manifestations of sepsis, the sensitivity of blood cultures drawn shortly after treatment initiation is reduced...
September 18, 2019
by drugs
Combo Antithrombotic Therapy Increases Bleeding Risk
Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone...
September 18, 2019
by drugs